Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

Subjects:

The role of glyoxalase system in methylglyoxal detoxification. by MohammedBashar Al-Qazzan (22439236)

Subjects:

IC₅₀ values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tes... by MohammedBashar Al-Qazzan (22439236)

Subjects:

3D and 2D pose of the docked Shikonin diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

Subjects:

Classification of inactive compounds. by MohammedBashar Al-Qazzan (22439236)

Subjects:

Active compounds identified as glyoxalase-I inhibitors. by MohammedBashar Al-Qazzan (22439236)

Subjects:

The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are display... by MohammedBashar Al-Qazzan (22439236)

Subjects:

3D and 2D pose of the docked Tolcapone diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

Subjects:

Metabolic analysis of cecal contents. by Ye Cheng (513097)

Subjects:

Staining of colonic tissue sections in rats. by Ye Cheng (513097)

Subjects:

Different metabolite quantities between groups. by Ye Cheng (513097)

Subjects:

Evaluation parameters of Orthogonal Projections to Latent Structure-Discriminant Analysis (OPLS-DA) in positive ion mode. by Ye Cheng (513097)

Subjects:

16S rRNA sequence analysis of intestinal microbiota in rats. by Ye Cheng (513097)

Subjects:

Quantitative results of immunohistochemical staining. by Ye Cheng (513097)

Subjects:

Fig 6 - by Samuel Hylander (331771)

Model of the role of increased ROS in chromosome missegregation. by Zachary J. Hough (20840430)

Fig 1 - by Samuel Hylander (331771)

Fig 3 - by Samuel Hylander (331771)

Fig 4 - by Samuel Hylander (331771)

Minimal data set. by Pornpan Chalermkitpanit (22110121)

“…Patients with favorable responses demonstrated a significant reduction in serum IFN-γ, IL-1β, IL-6, and GM-CSF concentration at 2 weeks after TFESI compared to their baseline levels. …”